Dermatologikum Hamburg

Patch testing hydroperoxides of limonene and linalool in consecutive patients—Results of the IVDK 2018–2020 (2023) Schubert S, Geier J, Brans R, Heratizadeh A, Kränke B, Schnuch A, Bauer A, et al. Journal article Relevant Aspects on cutaneous Leishmaniasis in Mallorca (2022) Burmann SN, Sunderkoetter C, Boeer-Auer A, Oellig F, Fischer M, Bogdan C, Michalowitz AL, Kreuter A Journal article, Letter Relevante Aspekte zur kutanen Leishmaniose auf Mallorca (2022) Burmann SN, Sunderkötter C, Böer-Auer A, Oellig F, Fischer M, Bogdan C, Michalowitz AL, Kreuter A Journal article Very late reactions in the patch test with fragrance mix I and oak moss absolute: Data of the Information Network of Departments of Dermatology (IVDK) (2021) Schubert S, Schnuch A, Bauer A, Wagner N, Schroeder-Kraft C, Dickel H, Weisshaar E, et al. Journal article A prognostic gene signature expressed in primary cutaneous melanoma: Synergism with conventional staging (2018) Brunner G, Heinecke A, Falk TM, Ertas B, Bloedorn-Schlicht N, Schulze HJ, Suter L, et al. Journal article A matter of perspective: Imputation methods and their effects illustrated with the use of data from the PRIME study (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution Molecular diagnosis of skin infections using paraffin-embedded tissue - review and interdisciplinary consensus (2018) Sunderkoetter C, Becker K, Kutzner H, Meyer T, Bloedorn-Schlicht N, Reischl U, Nenoff P, et al. Journal article Fumaric Acid Esters: Patient Characteristics and Duration of Therapy from the PsoBest German Psoriasis Registry (2017) Augustin M, Reich K, Spehr C, Rustenbach SJ, Mrowietz U, Radtke MA, Wilsman-Theis D, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without previous Systemic Therapy for Improvement of Skin Symptoms: PASI and IGA mod. 2011-Results of the PRIME Study (2017) Reich K, Mrowietz U, Augustin M, Thaci D, Kneidl J, Hentschke C, Simang M, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with respect to the Improvement of quality of life: DLQI and SF-36 Results of the PRIME Study (2017) Augustin M, Thaci D, Reich K, Mrowietz U, Kneidl J, Hentschke C, Simang M, et al. Conference contribution